Review and Update of Current Clinical Psychedelic Research

Review and Update on Clinical Psychedelic Research
San Jose, 2nd Floor
We are now in the midst of a psychedelic research renaissance, with clinical studies under way at top medical schools and research institutes worldwide. To date, the results have shown that psychedelic-assisted therapy is more effective than conventional treatments for easing anxiety in the dying, interrupting the hold of addictive drugs, alleviating post-traumatic stress disorder, and treating other psychological conditions.  The idea of psychedelics as powerful psychiatric medicines is now beginning to be re-accepted by the medical community. What does this mean? And What new directions will the future hold? 

Moderator: Ralph Metzner, President, Green Earth Foundation

• Rick Doblin, Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS)          
• Amanda Feilding, Executive Director, Beckley Foundation
• Charles Grob, Director, Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center, and Professor of Psychiatry and Pediatrics at the UCLA School of Medicine